Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sancy A Leachman

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Frontiers in Medicine|March 27, 2026
Correction: Oregon primary care providers as a frontline defense in the War on Melanoma™: improving access to melanoma educationAlyssa L Becker, Jacob H Nelson, Alex Verdieck-Devlaeminck, et al.
Frontiers in Medicine|March 31, 2025
Oregon primary care providers as a frontline defense in the War on Melanoma™: improving access to melanoma educationAlyssa L Becker, Jacob H Nelson, Alex Verdieck-Devlaeminck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2021
The State of Melanoma: Emergent Challenges and OpportunitiesMichael B Atkins, Clara Curiel-Lewandrowski, David E Fisher, et al.
Pigment Cell & Melanoma Research|April 19, 2016
The state of melanoma: challenges and opportunitiesGlenn Merlino, Meenhard Herlyn, David E Fisher, et al.
Cancer Research|October 19, 2006
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMELAlisa M Goldstein, May Chan, Mark Harland, et al.
The Journal of Investigative Dermatology|August 24, 2017
Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma FamiliesNicholas J Taylor, Nandita Mitra, Alisa M Goldstein, et al.
Cancer|October 4, 2018
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trialsJoanne M Jeter, Tawnya L Bowles, Clara Curiel-Lewandrowski, et al.
JAMA Dermatology|March 15, 2023
Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile TestingMohammed Kashani-Sabet, Sancy A Leachman, Jennifer A Stein, et al.
JAMA Dermatology|July 30, 2020
Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical BenefitDouglas Grossman, Nwanneka Okwundu, Edmund K Bartlett, et al.
Melanoma Management|August 1, 2017
Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversyMariah M Johnson, Sancy A Leachman, Lisa G Aspinwall, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Frontiers in Medicine|March 27, 2026
Correction: Oregon primary care providers as a frontline defense in the War on Melanoma™: improving access to melanoma educationAlyssa L Becker, Jacob H Nelson, Alex Verdieck-Devlaeminck, et al.
Frontiers in Medicine|March 31, 2025
Oregon primary care providers as a frontline defense in the War on Melanoma™: improving access to melanoma educationAlyssa L Becker, Jacob H Nelson, Alex Verdieck-Devlaeminck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2021
The State of Melanoma: Emergent Challenges and OpportunitiesMichael B Atkins, Clara Curiel-Lewandrowski, David E Fisher, et al.
Pigment Cell & Melanoma Research|April 19, 2016
The state of melanoma: challenges and opportunitiesGlenn Merlino, Meenhard Herlyn, David E Fisher, et al.
Cancer Research|October 19, 2006
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMELAlisa M Goldstein, May Chan, Mark Harland, et al.
The Journal of Investigative Dermatology|August 24, 2017
Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma FamiliesNicholas J Taylor, Nandita Mitra, Alisa M Goldstein, et al.
Cancer|October 4, 2018
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trialsJoanne M Jeter, Tawnya L Bowles, Clara Curiel-Lewandrowski, et al.
JAMA Dermatology|March 15, 2023
Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile TestingMohammed Kashani-Sabet, Sancy A Leachman, Jennifer A Stein, et al.
JAMA Dermatology|July 30, 2020
Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical BenefitDouglas Grossman, Nwanneka Okwundu, Edmund K Bartlett, et al.
Melanoma Management|August 1, 2017
Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversyMariah M Johnson, Sancy A Leachman, Lisa G Aspinwall, et al.
Pageof 14